NCT02366962View on ClinicalTrials.gov

A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older

PHASE3CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
InfluenzaVaccine
Interventions
BIOLOGICAL

ASP7374

subcutaneous

Trial Locations (1)

Unknown

Fukuoka

All Listed Sponsors
lead

UMN Pharma Inc.

INDUSTRY

NCT02366962 - A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older | Biotech Hunter | Biotech Hunter